Skip to Main Content

Paper Details

SLC19A1 transports immunoreactive cyclic dinucleotides.
Nature
205
2019
2'3'-cGAMP, CDN, CDNs, Cytosolic DNA, DNA, IRF3, NF-B, SLC19A1, STING, STING8, activated B cells, cGAS, cancer, cancer13, cyclic GMP-AMP, cyclic GMP-AMP synthase, cyclic dinucleotide, cyclic dinucleotides, cyclic guanosine monophosphate-adenosine monophosphate (2'3'-cGAMP)4-, cytosol, folate, folate-organic phosphate, folates, human, human cell lines, human cells, inflammatory diseases, interferon regulatory factor 3, malignant, malignant cells9, methotrexate, nuclear factor -light-chain-enhancer of activated B cells, phosphate, primary cells, reduced, stimulator of interferon genes, sulfasalazine, target cells, type I interferons
Author NameAffiliation
Stacia K WymanInnovative Genomics Institute, University of California berkeley
Nicholas E GarelisUniversity of California berkeley
Jacob E CornInnovative Genomics Institute, University of California berkeley
Jacob E CornUniversity of California berkeley
Jacob E CornInstitute of Molecular Health Sciences, ETH Zurich
  • 1 - 5

Datasets

Release 1.2